Heptamidine dimethanesulfonate NEW
| Price | $39 | $89 | $135 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-09-04 |
Product Details
| Product Name: Heptamidine dimethanesulfonate | CAS No.: 161374-55-6 |
| Purity: 98.24% | Supply Ability: 10g |
| Release date: 2025/09/04 |
Product Introduction
Bioactivity
| Name | Heptamidine dimethanesulfonate |
| Description | Heptamidine dimethanesulfonate (SBi4211 dimethanesulfonate) serves as a potent inhibitor related to Pentamidine, targeting the calcium-binding protein S100B with a dissociation constant (Kd) of 6.9 µM. It demonstrates specificity by preferentially killing melanoma cells overexpressing S100B compared to cells lacking this protein. Additionally, Heptamidine is employed as a valuable research tool in the study of Myotonic dystrophy (DM). |
| In vitro | Heptamidine rescues the mis-splicing of minigene reporters in a HeLa cell DM1 model (EC50: 15 μM). Heptamidine (20 μM) does not decrease CUG levels significantly when compares to Propamidine and Pentamidine, and exhibits cytotoxic at concentrations above 17.5 μM in HeLa cells expressing 960 CUG repeats [2]. |
| In vivo | Heptamidine (i.p.; 20 or 30 mg/kg; 7 days) causes a dose-dependent reduction of exon 7a inclusion in HSALR mice, returning to wild type levels (6±1%) when at 20 mg/kg dose, the myotonia is reduced from grade 3 to grade 1 (occasional myotonic discharge) or grade 0 at both 20 or 30 mg/kg [2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 8.33 mg/mL (14.86 mM), Sonication is recommended. DMSO : 70 mg/mL (124.85 mM), Sonication is recommended. |
| Keywords | SBi-4211 | SBi4211 | SBi 4211 | S100B | Myotonic | melanoma | Inhibitor | inhibit | Heptamidine dimethanesulfonate | Heptamidine | HeLa | dystrophy | cell | cancer | calcium-binding protein S100B | Calcium-Binding |
| Related Compound Libraries | Bioactive Compound Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $89.00/100mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-09-16 | |
| $2.00/100KG |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-07-10 | |
| $39.00/1mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-09-11 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY